IgG and IgM are two types of antibodies your immune system produces, but they serve different roles and appear at different stages of an infection. IgM is the first responder, produced early when your body encounters a new threat. IgG arrives later, lasts much longer, and makes up about 75% of all antibodies in your blood. Understanding the difference between these two helps explain how your immune system fights infections and why doctors test for each one separately.
Structure and Size
IgG is a relatively small, Y-shaped molecule called a monomer. It has two binding sites where it can latch onto a pathogen. IgM, on the other hand, is a heavyweight. It circulates as a pentamer, meaning five Y-shaped units linked together by chemical bonds into a single large complex. This gives IgM up to ten potential binding sites, though in practice steric constraints mean fewer are active at once. The size difference matters: IgM’s bulk makes it highly effective at clumping pathogens together in the bloodstream, while IgG’s smaller size lets it move into tissues and cross barriers that IgM cannot.
When Each Antibody Appears
When you’re exposed to a pathogen for the first time, your immune system launches what’s called a primary response. IgM is the default antibody produced by newly activated immune cells. It typically becomes detectable within a few days to about a week after symptoms begin, though the exact timing varies by infection. Your body then undergoes a process called class switching, where immune cells stop making IgM and start producing IgG instead. This transition usually happens within the first two weeks.
During a second exposure to the same pathogen, the response looks very different. Memory cells that were created during the first infection kick in quickly and produce large amounts of IgG almost immediately, with little or no IgM. This is the secondary immune response, and it’s why vaccines work: they prime your body to skip the slow IgM phase and jump straight to a fast, powerful IgG response.
How Long They Last
IgM is short-lived. After the initial immune response peaks, IgM antibodies have a half-life of roughly 5 days, meaning their levels drop by half every 5 days. In studies of rubella infection, IgM antibodies persisted for only about 43 to 80 days total before disappearing. IgG is far more durable. Its levels decline very slowly after peaking, often remaining detectable for months, years, or even a lifetime depending on the infection. This persistence is the basis of long-term immunity.
Concentration in Your Blood
IgG dominates your bloodstream. Normal adult levels range from about 700 to 1,600 mg/dL, making it the most abundant antibody class by a wide margin. IgM is present in much smaller quantities, typically between 40 and 230 mg/dL. The roughly tenfold difference in concentration reflects their different roles: IgG handles the ongoing, day-to-day surveillance work of immunity, while IgM serves as a temporary first line of defense.
Activating the Complement System
Both IgG and IgM can trigger the complement system, a cascade of proteins that punches holes in pathogens and flags them for destruction. But they do this with very different efficiency. A single IgM pentamer, with its multiple arms clustered together, is extremely effective at activating complement because it provides the dense binding surface that the complement protein C1q needs to dock onto. IgG molecules work individually and need to cluster together on a pathogen’s surface before they can recruit C1q effectively. Among IgG’s four subclasses, IgG1 and IgG3 are the strongest complement activators, while IgG2 is weak and IgG4 barely activates complement at all.
Crossing the Placenta
IgG is the only antibody class that crosses the placenta in significant amounts. A specialized receptor on placental cells actively transports IgG from the mother’s blood into the fetal circulation. This gives newborns a temporary supply of the mother’s antibodies, protecting them during the first months of life before their own immune system matures. IgM cannot cross the placenta because of its large pentameric size. If a newborn tests positive for IgM against a specific pathogen, it means the baby’s own immune system produced those antibodies, which can be a sign of infection acquired in the womb.
The Four IgG Subclasses
IgG comes in four subtypes, numbered IgG1 through IgG4 in order of abundance. IgG1 is the workhorse, making up about 67% of total IgG. It responds strongly to protein-based threats like viruses and bacterial toxins. IgG2 accounts for about 22% and tends to target carbohydrate structures on the surface of certain bacteria. IgG3 makes up about 7% and is a potent trigger of inflammation, though its shorter half-life keeps inflammatory responses from spiraling out of control. IgG4, the rarest at roughly 4%, plays a more regulatory role and is sometimes called a “blocking antibody” because it dampens immune reactions rather than amplifying them. Despite being more than 90% identical at the molecular level, these subclasses have distinct profiles for complement activation, pathogen clearance, and interaction with immune cells.
What Antibody Tests Tell You
Doctors often test for IgM and IgG separately because each tells a different part of the story. The traditional interpretation is straightforward: IgM positive with IgG negative suggests a recent or current infection, since IgM appears first. IgG positive with IgM negative suggests a past infection or successful vaccination, since IgG persists long after IgM fades. When both are positive, the infection is likely in a transitional phase, somewhere between active and resolving.
In practice, this framework is a simplification. Studies during the COVID-19 pandemic showed that IgG and IgM often appeared simultaneously, and in some patients IgG was actually detectable a day earlier than IgM. The sensitivity of antibody testing also depends heavily on timing. In the first week of illness, antibody tests of any kind catch fewer than a third of infections. After two weeks, combined IgM and IgG testing picks up roughly 64% of cases. This is why antibody testing is better suited for confirming past infection than diagnosing active illness, where direct pathogen detection methods are more reliable.
Quick Comparison
- Structure: IgG is a monomer with 2 binding sites; IgM is a pentamer with up to 10
- Blood concentration: IgG makes up about 75% of serum antibodies; IgM about 10%
- Timing: IgM appears first in a new infection; IgG dominates the later and secondary response
- Half-life: IgM lasts roughly 5 days; IgG persists for weeks to years
- Complement activation: IgM is the most efficient single activator; IgG requires clustering
- Placental transfer: IgG crosses the placenta; IgM does not
- Subclasses: IgG has four (IgG1–4) with specialized roles; IgM has none